DE3764700D1 - Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff. - Google Patents

Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.

Info

Publication number
DE3764700D1
DE3764700D1 DE8787400964T DE3764700T DE3764700D1 DE 3764700 D1 DE3764700 D1 DE 3764700D1 DE 8787400964 T DE8787400964 T DE 8787400964T DE 3764700 T DE3764700 T DE 3764700T DE 3764700 D1 DE3764700 D1 DE 3764700D1
Authority
DE
Germany
Prior art keywords
producing
organic acid
active substance
aqueous pharmaceutical
pharmaceutical solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787400964T
Other languages
English (en)
Inventor
Florence Maurin
Claude Coquelet
Alain Tournoux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Chauvin SAS
Original Assignee
Laboratoires Chauvin SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Chauvin SAS filed Critical Laboratoires Chauvin SAS
Application granted granted Critical
Publication of DE3764700D1 publication Critical patent/DE3764700D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8787400964T 1986-04-30 1987-04-24 Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff. Expired - Lifetime DE3764700D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8606346A FR2598081B1 (fr) 1986-04-30 1986-04-30 Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique

Publications (1)

Publication Number Publication Date
DE3764700D1 true DE3764700D1 (de) 1990-10-11

Family

ID=9334832

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787400964T Expired - Lifetime DE3764700D1 (de) 1986-04-30 1987-04-24 Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.

Country Status (8)

Country Link
US (1) US4866088A (de)
EP (1) EP0244315B1 (de)
JP (1) JPH0749373B2 (de)
AT (1) ATE56139T1 (de)
DE (1) DE3764700D1 (de)
ES (1) ES2017098B3 (de)
FR (1) FR2598081B1 (de)
GR (1) GR3000838T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
JPH0248526A (ja) * 1988-08-08 1990-02-19 Sumitomo Pharmaceut Co Ltd インドメタシン注射剤およびその製造方法
WO1991001718A1 (fr) * 1989-08-03 1991-02-21 Eisai Co., Ltd. Procede de photostabilisation pour collyre liquide et collyre liquide photostabilise
CA2021441A1 (en) * 1989-08-18 1991-02-19 Alberto Ferro Process for the manufacture of parenteral application formulations
FR2670675B1 (fr) * 1990-12-20 1993-04-16 Lafon Labor Procede de preparation de formes pharmaceutiques stables a base d'acide acetylsalicylique ou de ses sels.
TW274516B (de) * 1993-11-12 1996-04-21 Ciba Geigy Ag
JPH10510540A (ja) * 1994-12-12 1998-10-13 オメロス メディカル システムズ，インコーポレーテッド 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法
ATE532530T1 (de) * 1994-12-12 2011-11-15 Omeros Corp Bespüllungslösung und deren verwendung zur perioperativen hemmung von schmerzen, entzündungen und/oder spasmen an einer gefässstruktur
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
FR2738149B1 (fr) * 1995-09-06 1997-11-14 Chauvin Lab Sa Collyre a base d'indometacine pret a l'emploi
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20090136505A1 (en) * 2005-02-23 2009-05-28 Johanna Bentz Intranasal Administration of Active Agents to the Central Nervous System
EP2179736A4 (de) * 2007-08-09 2012-01-18 Senju Pharma Co Pirenoxinhaltige zweikomponenten-augentropfen
CN103933063A (zh) * 2007-11-30 2014-07-23 托尔特克制药有限责任公司 用于治疗阴道感染和致病性阴道生物被膜的组合物和方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3193459A (en) * 1955-07-01 1965-07-06 Upjohn Co Steroid hemisuccinate compositions and method for extemporaneous administration
ES415972A1 (es) * 1973-06-15 1974-04-01 Inst Llorente S A Procedimiento para la preparacion de soluciones inyectablesde complejos de indicacion antineuritica, de vitaminas, co- fermentos, y sus asociaciones.
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
US4443432A (en) * 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
JPS58152811A (ja) * 1982-03-08 1983-09-10 Sumitomo Chem Co Ltd インドメタシン点眼組成物
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤

Also Published As

Publication number Publication date
JPS6393712A (ja) 1988-04-25
FR2598081B1 (fr) 1990-02-02
GR3000838T3 (en) 1991-11-15
US4866088A (en) 1989-09-12
FR2598081A1 (fr) 1987-11-06
EP0244315B1 (de) 1990-09-05
JPH0749373B2 (ja) 1995-05-31
ES2017098B3 (es) 1991-01-01
EP0244315A1 (de) 1987-11-04
ATE56139T1 (de) 1990-09-15

Similar Documents

Publication Publication Date Title
DE3764700D1 (de) Verfahren zur herstellung einer waessrigen pharmazeutischen loesung einer organischen saeure als wirkstoff.
DE3868700D1 (de) Verfahren zur herstellung eines optisch aktiven alkohols.
ATE75779T1 (de) Verfahren zur herstellung von optisch aktiven cyanhydrinen.
DE3874619D1 (de) Herstellungsverfahren eines optisch aktiven alkohols.
DE3882242D1 (de) Fermentationsverfahren zur herstellung von 2-keto-l-gulonsaeuren.
PT83825A (de) Mittel zur bestimmung von peroxidase-aktivitaet mit stabilisator verfahren zur herstellung und seine verwendung
DE69004066D1 (de) Verfahren zur photostabilisierung von augenspüllösungen.
ATE14597T1 (de) Verfahren zur enzymatischen herstellung von l-2- amino-4-methylphosphinobuttersaeure.
DE3861738D1 (de) Verfahren zur herstellung konzentrierter waessriger farbstoffzubereitungen.
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
ATE49969T1 (de) Verfahren zur herstellung von pteridinderivaten.
DE59001820D1 (de) Verfahren zur herstellung von indolcarbonsaeurederivaten.
DE3867745D1 (de) Verfahren zur herstellung von aromatischen aldehyden.
ATE69795T1 (de) Verfahren zur herstellung von ethylenischen carbonylverbindungen.
SE7905659L (sv) Medel for behandling av seborreiska tillstand
DE69704475D1 (de) Verfahren zur Herstellung von 13-cis-Retinsäure
ATA166985A (de) Verfahren zur herstellung von 7-amino-3alkoxymethyl-3-cephem-4-carbonsaeuren
EP0311969A3 (de) Verfahren zur Herstellung von Triphendioxazinen
ATE41919T1 (de) Verfahren zur herstellung von gegebenenfalls in 5-stellung halogenisierten 6-(nieder)-alkoxy-1naphthoes|urenund den entsprechenden estern.
ATE92909T1 (de) Verfahren zur herstellung von optischen isomeren von estern der 2-chlorpropionsaeure.
DE3680121D1 (de) Verfahren zur herstellung von optisch aktiven glycerol-derivaten.
ATE37873T1 (de) Verfahren zur herstellung optisch aktiver 1,4dihydropyridine.
ATA623478A (de) Verfahren zur herstellung von optisch aktiven, gegebenenfalls substituierten 2-amino-2-phenyl- essigsaeuren
DE3778380D1 (de) Verfahren zur herstellung organischer hydroxamsaeureester.
DE3851942D1 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition